Pharmacy and Therapeutics September 2016 : Cover 1

Register and Formulary Visit At Product September 2016 Volume 41 Number 9 For A Peer-Reviewed Journal for Managed Care and Formulary Management Decision-Makers Data Value Purchasing Programs Make Plodding Progress Drug Manufacturers Question Some Pay-for-Performance Methodologies S. Barlas VISIT US ONLINE AT WWW.PTCOMMUNITY.COM Covering the Cost of the Cure From Hepatitis C to Cancer, New Therapies Are Straining a System Plagued by Ineffi ciency P. Sonnenreich and L. Geisler HEALTH CARE & LAW Telehealth: Applications From a Legal and Regulatory Perspective R. M. Marcoux, RPh, MBA; and F. R. Vogenberg, RPh, PhD Q&A DRUG FORECAST William B. White Explains the Changes In the Way We Look at Blood Pressure Which Numbers Matter Most— And Why Can They Be Deceptive? J. McCain Aripiprazole Lauroxil (Aristada) An Extended-Release, Long-Acting Injection For the Treatment of Schizophrenia M. P. Cruz, PharmD, CGP, BCPP, FASCP MEETING HIGHLIGHTS ESMO World Congress On Gastrointestinal Cancer And European Post-Chicago Melanoma/Skin Cancer Meeting W. Alexander

Next Page

Publication List
Using a screen reader? Click Here